Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 583

1.

Association between apolipoprotein E4 and cognitive decline in elderly adults.

Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group.

J Am Geriatr Soc. 2007 Nov;55(11):1777-85.

PMID:
17979899
[PubMed - indexed for MEDLINE]
2.

Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.

Yaffe K, Cauley J, Sands L, Browner W.

Arch Neurol. 1997 Sep;54(9):1110-4.

PMID:
9311354
[PubMed - indexed for MEDLINE]
3.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
[PubMed - indexed for MEDLINE]
4.

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE.

J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x.

PMID:
19278396
[PubMed - indexed for MEDLINE]
5.

Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.

Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.

Stroke. 2000 Oct;31(10):2431-6.

PMID:
11022076
[PubMed - indexed for MEDLINE]
Free Article
6.

Does low to moderate alcohol intake protect against cognitive decline in older people?

Stott DJ, Falconer A, Kerr GD, Murray HM, Trompet S, Westendorp RG, Buckley B, de Craen AJ, Sattar N, Ford I.

J Am Geriatr Soc. 2008 Dec;56(12):2217-24. doi: 10.1111/j.1532-5415.2008.02007.x.

PMID:
19093921
[PubMed - indexed for MEDLINE]
7.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
[PubMed - indexed for MEDLINE]
8.

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE.

J Neurol Sci. 2001 Aug 15;189(1-2):93-8.

PMID:
11535238
[PubMed - indexed for MEDLINE]
9.

Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.

Vinkers DJ, Stek ML, van der Mast RC, de Craen AJ, Le Cessie S, Jolles J, Westendorp RG, Gussekloo J.

Neurology. 2005 Jul 12;65(1):107-12.

PMID:
16009894
[PubMed - indexed for MEDLINE]
10.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
[PubMed - indexed for MEDLINE]
11.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
[PubMed - indexed for MEDLINE]
12.

Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults.

Ng TP, Niti M, Feng L, Kua EH, Yap KB.

J Am Geriatr Soc. 2009 Jan;57(1):101-6. doi: 10.1111/j.1532-5415.2008.02086.x. Epub 2008 Nov 19.

PMID:
19054180
[PubMed - indexed for MEDLINE]
13.

Apolipoprotein E genotype and lifetime cognitive decline.

Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG.

Int Psychogeriatr. 2008 Feb;20(1):109-23. Epub 2007 Aug 22.

PMID:
17711604
[PubMed - indexed for MEDLINE]
14.

[Apolipoprotein E4 and memory decline in the elderly].

Jonker C, Dik MG, van Kamp GJ, Deeg DJ.

Tijdschr Gerontol Geriatr. 2000 Oct;31(5):198-202. Dutch.

PMID:
11064931
[PubMed - indexed for MEDLINE]
15.

Activation of hemostasis and decline in cognitive function in older people.

Stott DJ, Robertson M, Rumley A, Welsh P, Sattar N, Packard CJ, Shepherd J, Trompet S, Westendorp RG, de Craen AJ, Jukema JW, Buckley B, Ford I, Lowe GD.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):605-11. doi: 10.1161/ATVBAHA.109.199448. Epub 2009 Dec 23.

PMID:
20032290
[PubMed - indexed for MEDLINE]
Free Article
16.

Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M.

Arch Neurol. 2007 Jun;64(6):862-71.

PMID:
17562935
[PubMed - indexed for MEDLINE]
17.

Apolipoprotein e4 allele and cognitive decline in elderly men.

Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D.

BMJ. 1994 Nov 5;309(6963):1202-6.

PMID:
7987151
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Serum calcium and cognitive function in old age.

Schram MT, Trompet S, Kamper AM, de Craen AJ, Hofman A, Euser SM, Breteler MM, Westendorp RG.

J Am Geriatr Soc. 2007 Nov;55(11):1786-92.

PMID:
17979900
[PubMed - indexed for MEDLINE]
19.

Rate of memory decline in AD is related to education and occupation: cognitive reserve?

Stern Y, Albert S, Tang MX, Tsai WY.

Neurology. 1999 Dec 10;53(9):1942-7.

PMID:
10599762
[PubMed - indexed for MEDLINE]
20.

Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.

Dement Geriatr Cogn Disord. 2007;23(5):327-33. Epub 2007 Mar 19.

PMID:
17374951
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk